ERBB2 and cancer: Similarly, Li et al. modified IgG antibodies onto the glycocalyx on the NK surface to obtain Herceptin-NK-92MI, exhibiting enhanced activity in vitro, and induce the lysis and death of HER2+ cancer cells [119].